Thyroid-Stimulating hormone and metabolic cardiovascular risk markers from weighted two-wave analyses of india with an exploratory Chinese inpatient comparison

Evidence on thyroid-stimulating hormone (TSH) and metabolic cardiovascular risk markers in South Asian older adults is limited. We examined cross-sectional and two-wave associations in Harmonized LASI-DAD and conducted a cautiously interpreted Chinese inpatient comparison. We analysed Harmonized LASI-DAD Version B1 ( n = 6,168; Wave 1 collected 2017–2019 and Wave 2 collected 2022–2024). TSH was log-transformed. Weighted Wave 1 and Wave 2 models used biomarker weights; two-wave models used the longitudinal respondent weight and adjusted for the baseline value of the continuous outcome. The primary model adjusted for age, sex, body mass index (BMI), education, marital status, and rural/urban residence, where applicable. Benjamini–Hochberg false-discovery-rate (FDR) values were reported across outcomes within each model family. An ancillary retrospective, de-identified, same-visit inpatient electronic medical record (EMR) analysis from Jilin University First Hospital included 251 records after one pre-specified TSH plausibility exclusion. At Wave 1, higher log(TSH) was associated with LDL cholesterol (β = 2.26 mg/dL, 95% CI 0.53 to 4.00; nominal p = 0.0105; FDR p = 0.063) and total cholesterol (β = 2.68 mg/dL, 0.71 to 4.64; p = 0.0077; FDR p = 0.063). These associations persisted in a multiple-imputation sensitivity analysis (LDL β = 2.43, 0.93 to 3.94; total cholesterol β = 2.83, 1.06 to 4.59; both FDR p = 0.0025). Wave 2 and two-wave primary estimates for these outcomes were imprecise and included the null. Jilin estimates were also imprecise (LDL β = 0.90, − 3.90 to 5.71; total cholesterol β = 1.41, − 4.91 to 7.74; BMI β = 0.49, − 0.25 to 1.23). The weighted Wave 1 findings provide modest, cross-sectional evidence of positive TSH–lipid associations in this LASI-DAD analytic sample. The results do not establish cardiovascular-event risk, longitudinal persistence, causality, or independent external validation.

Authors

Institutions

Publication Details

Journal
BMC Public Health
Published
2026-10-31
DOI
https://doi.org/10.1186/s12889-026-30019-2
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Thyroid-Stimulating hormone and metabolic cardiovascular risk markers from weighted two-wave analyses of india with an exploratory Chinese inpatient comparison

Xudong Sun, Bowen Chen, Peixin Gu, Xiaoshan Yue
BMC Public Health
Thyroid Disorders and Treatments
article

Thyroid-Stimulating hormone and metabolic cardiovascular risk markers from weighted two-wave analyses of india with an exploratory Chinese inpatient comparison

Xudong Sun, Bowen Chen, Peixin Gu, Xiaoshan Yue
article en

Abstract

Evidence on thyroid-stimulating hormone (TSH) and metabolic cardiovascular risk markers in South Asian older adults is limited. We examined cross-sectional and two-wave associations in Harmonized LASI-DAD and conducted a cautiously interpreted Chinese inpatient comparison. We analysed Harmonized LASI-DAD Version B1 ( n = 6,168; Wave 1 collected 2017–2019 and Wave 2 collected 2022–2024). TSH was log-transformed. Weighted Wave 1 and Wave 2 models used biomarker weights; two-wave models used the longitudinal respondent weight and adjusted for the baseline value of the continuous outcome. The primary model adjusted for age, sex, body mass index (BMI), education, marital status, and rural/urban residence, where applicable. Benjamini–Hochberg false-discovery-rate (FDR) values were reported across outcomes within each model family. An ancillary retrospective, de-identified, same-visit inpatient electronic medical record (EMR) analysis from Jilin University First Hospital included 251 records after one pre-specified TSH plausibility exclusion. At Wave 1, higher log(TSH) was associated with LDL cholesterol (β = 2.26 mg/dL, 95% CI 0.53 to 4.00; nominal p = 0.0105; FDR p = 0.063) and total cholesterol (β = 2.68 mg/dL, 0.71 to 4.64; p = 0.0077; FDR p = 0.063). These associations persisted in a multiple-imputation sensitivity analysis (LDL β = 2.43, 0.93 to 3.94; total cholesterol β = 2.83, 1.06 to 4.59; both FDR p = 0.0025). Wave 2 and two-wave primary estimates for these outcomes were imprecise and included the null. Jilin estimates were also imprecise (LDL β = 0.90, − 3.90 to 5.71; total cholesterol β = 1.41, − 4.91 to 7.74; BMI β = 0.49, − 0.25 to 1.23). The weighted Wave 1 findings provide modest, cross-sectional evidence of positive TSH–lipid associations in this LASI-DAD analytic sample. The results do not establish cardiovascular-event risk, longitudinal persistence, causality, or independent external validation.

BMC Public Health
Zhejiang Chinese Medical University (CN), Jilin University (CN), First Hospital of Jilin University (CN)
Openalex Percentile: Top 10%
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon